E
Elvin Blanco
Researcher at Houston Methodist Hospital
Publications - 59
Citations - 8354
Elvin Blanco is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Drug delivery & Mitochondrion. The author has an hindex of 31, co-authored 54 publications receiving 6742 citations. Previous affiliations of Elvin Blanco include Rice University & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Principles of nanoparticle design for overcoming biological barriers to drug delivery
TL;DR: By successively addressing each of the biological barriers that a particle encounters upon intravenous administration, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.
Journal ArticleDOI
Functionalized Micellar Systems for Cancer Targeted Drug Delivery
TL;DR: The purpose of this review is to draw attention to the new developments of multi-functional polymer micelles for cancer therapy with special focus on tumor targeting and controlled drug release strategies.
Journal ArticleDOI
Multifunctional Micellar Nanomedicine for Cancer Therapy
TL;DR: This minireview will focus on recent advancements in the multifunctional design of micellar nanomedicine with tumor targeting, stimulated drug release, and cancer imaging capabilities.
Journal ArticleDOI
Nanomedicine in cancer therapy: Innovative trends and prospects
TL;DR: Several advancements in established nanoparticle technologies such as liposomes, polymer micelles, and dendrimers regarding tumor targeting and controlled release strategies are discussed, which are being incorporated into their design with the hope of generating a more robust and efficacious nanotherapeutic modality.
Journal ArticleDOI
An injectable nanoparticle generator enhances delivery of cancer therapeutics
Rong Xu,Rong Xu,Rong Xu,Guodong Zhang,Guodong Zhang,Junhua Mai,Junhua Mai,Xiaoyong Deng,Xiaoyong Deng,Xiaoyong Deng,Victor Segura-Ibarra,Suhong Wu,Jianliang Shen,Haoran Liu,Zhenhua Hu,Lingxiao Chen,Yi Huang,Eugene J. Koay,Eugene J. Koay,Yu Huang,Yu Huang,Jun Liu,Joe Ensor,Elvin Blanco,Xuewu Liu,Mauro Ferrari,Mauro Ferrari,Haifa Shen,Haifa Shen +28 more
TL;DR: Compared to its individual components or current therapeutic formulations, iNPG-pDox shows enhanced efficacy in MDA-MB-231 and 4T1 mouse models of metastatic breast cancer, including functional cures in 40–50% of treated mice.